Home » Topics » BioWorld Science

BioWorld Science
RSS

Sequana, Boehringer Mannheim closer to elucidating genetic basis of osteoporosis

Aug. 18, 1997

Vasopressin agonist from Otsuka

Aug. 18, 1997

Phase I trial of DiffGAM completed successfully

Aug. 18, 1997

Spanish scientists discover anxiolytic CCKA antagonist

Aug. 18, 1997

FDA proposes to require pediatric data on drugs

Aug. 18, 1997

U.S. patent issued for Candida albicans treatment method

Aug. 18, 1997

New biotech company formed to combat cardiovascular diseases

Aug. 18, 1997

Terrapin and Taiho sign development agreement for anticancer agent

Aug. 18, 1997

Astra: 1997 half-year highlights

Aug. 18, 1997

PharmaPrint submits IND for herbal BPH treatment

Aug. 18, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 10, 2026.
FENS 2026: Shedding light on the sheddome
BioWorld
At the recently opened FENS Forum 2026 in Barcelona – the Federation of European Neuroscience Societies’ flagship congress and Europe’s largest neuroscience...
Ionis, AZ shares down on unexpected Wainua flop in cardiomyopathy
BioWorld
News of the unexpected phase III failure of the gene silencing drug Wainua (eplontersen) in the treatment of transthyretin-mediated amyloid cardiomyopathy sent...
FENS 2026: Next-gen biologics take on brain disease
BioWorld
Whether by fine-tuning neurotransmitter signaling or silencing disease-associated genes, emerging biologic therapies are reshaping neuroscience drug development,...
Recombinant vaccine inhibits HBV-associated HCC growth
BioWorld Science
Chronic liver disease and hepatocellular carcinoma (HCC) associated with chronic hepatitis B virus (HBV) are serious health problems in highly endemic areas....